Indrayani Biotech Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth in the latest quarter indicates a return to prior levels, suggesting recovery in demand.
Profit margins improved significantly from previous quarters, reflecting better cost management.
Consistent growth in operating profit demonstrates operational efficiency and strong business fundamentals.

NEGATIVES

Revenue decline in the last quarter raises concerns about sustainability in the upcoming periods.
Net profit remains low compared to historical averages, signaling potential challenges ahead.
Higher expenses relative to revenue in recent quarters could pressure future profitability.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	42.31	40.44	39.09	44.38	31.53	30.81	17.32	29.10
Expenses	42.70	34.99	38.09	40.68	30.63	29.92	16.89	30.40
Operating Profit	-0.39	5.45	1	3.70	0.90	0.90	0.43	-1.30
Other Income	0.01	0.09	0.08	1.03	0.04	0.30	0	1.51
Interest	2.03	0.93	1.41	5.51	2.25	1.42	1.03	0.86
Depreciation	0.90	0.91	1.03	0.96	0.83	2.79	1.46	3.47
Profit Before Tax	-0.38	5.54	1.08	4.73	0.94	1.20	0.43	0.21
Tax	0.06	0	0	0	0.09	-0.02	0.08	0.05
Net Profit	-0.45	5.54	1.08	4.73	0.85	1.22	0.35	0.16
Eps in Rs	-0.06	0.89	0.22	0.58	0.10	0.13	0.05	0.03